Your Health, We Care
Rezurock is indicated for the treatment of adult and pediatric patients 12 years and older with chronic graft-versus-host disease (chronic GVHD) after failure of at least two prior lines of systemic therapy.
from FDA，2024.04
iIndicated for the treatment of adult and pediatric patients 12 years and older ···【more】
Release date：2026-01-05Recommended：0
